/주식/SEER
SEER

SEER

USD

Seer Inc. Class A Common Stock

$2.050+0.040 (1.990%)

실시간 가격

Healthcare
생명공학
미국

가격 차트

Loading Chart...

핵심 지표

시장 지표
기업 기본 정보
거래 통계

시장 지표

시가

$2.010

고가

$2.090

저가

$2.010

거래량

0.03M

기업 기본 정보

시가총액

122.6M

산업

생명공학

국가

United States

거래 통계

평균 거래량

0.25M

거래소

NMS

통화

USD

52주 범위

저가 $1.56현재가 $2.050고가 $2.625

AI 분석 리포트

마지막 업데이트: 2025년 5월 1일
AI 생성데이터 소스: Yahoo Finance, Bloomberg, SEC

SEER (Seer Inc. Class A Common Stock): Analyzing Recent Moves & What Might Come Next

Stock Symbol: SEER Generate Date: 2025-05-01 15:05:34

Let's break down what's been happening with Seer stock and what the data we have might suggest.

Recent News Buzz

The main piece of news we've got is pretty straightforward: Seer announced they'll be reporting their first quarter 2025 financial results on May 13th. This isn't news about a big breakthrough or a problem; it's just setting a date for when we'll get an update on how the company is actually doing financially.

Now, interestingly, the analysis provided points to overall "positive news sentiment" with a high confidence score. This suggests that while this specific announcement is neutral, the general feeling from other news or discussions out there might be leaning favorable for Seer right now. Earnings reports are always a big deal, though. They can really move the stock depending on whether the results beat expectations, miss them, or if the company says something surprising about the future. So, mark May 13th on your calendar if you're watching this one.

Price Check: What the Chart Shows

Looking back over the last few months, the picture for SEER has been a bit rough. The stock was trading up around the $2.30 mark back in February, but it saw a pretty significant slide through March, dipping into the $1.60s at its lowest point.

April brought a bit of a bounce-back, with the price climbing back towards the $2.10 area. However, in the last week or so of April and into early May, it's pulled back slightly again. The current price is hovering right around the $2.00 level.

So, the longer trend has been down, but there was a noticeable recovery attempt in April. Lately, it's seen a small dip from that recent high.

What about the very near future? The AI prediction we have suggests small increases over the next couple of days: about 1.5% today, 1.7% tomorrow, and 2.1% the day after. This points to the AI seeing a little upward nudge coming right away.

Putting It Together: Outlook & Ideas

Based on the mix of information – the reported positive sentiment, the recent price bounce (despite the longer-term downtrend), and the AI's prediction for immediate small gains – the very near-term picture might have a slight upward lean, but it's definitely mixed and cautious. The upcoming earnings report is the big unknown that could change everything.

The analysis provided also highlights some interesting points:

  • Some technical indicators suggest potential buying pressure and a bullish trend, while others, like the MACD, show a bearish signal. It's a bit of a technical tug-of-war.
  • Fundamentally, the company's valuation looks attractive compared to its industry (low P/E relative to peers), which is a plus for value investors. But, on the flip side, it's showing negative revenue growth and has high debt, which are definite concerns.

Given the current price is right around $2.00, and the provided recommendation data suggests potential entry points near $1.98 and $2.00, this area could be considered a spot to watch if you're interested in this stock, aligning with the idea of being near a potential support level.

For managing risk, the recommendation data suggests a potential stop-loss around $1.78. This is below the recent lows and could be a level to consider if the price starts heading south again, especially if the upcoming earnings disappoint. On the upside, a potential take-profit level mentioned is $2.02, which is very close to the current price and the AI's short-term prediction. This suggests the immediate upside might be seen as limited by some models, or perhaps it's a quick scalp target.

Remember, this stock is considered higher risk (level 4) and might be more suitable for investors comfortable with more aggressive strategies or those looking for potential value plays.

Company Context

Just a quick reminder about Seer: they are a life sciences company working on technology for studying proteins (proteomics). They sell their products mainly for research use. They are a relatively small company with a market cap around $119 million and are not currently profitable (hence the negative P/E ratio). This means their stock can be more volatile and sensitive to news, especially news about their sales and financial performance, which is exactly what the May 13th report will cover.


Disclaimer: This analysis is based solely on the provided data and is for informational purposes only. It is not financial advice. Stock investing involves significant risk, and you could lose money. Always conduct your own thorough research and consider consulting with a qualified financial advisor before making any investment decisions.

관련 뉴스

GlobeNewswire

Seer to Report First Quarter 2025 Financial Results on May 13, 2025

REDWOOD CITY, Calif., April 24, 2025 (GLOBE NEWSWIRE) -- Seer, Inc. (NASDAQ:SEER), a leading life sciences company commercializing a disruptive new platform for proteomics, today announced that it will report financial

더 보기
Seer to Report First Quarter 2025 Financial Results on May 13, 2025

AI 예측Beta

AI 추천

강세

업데이트 시간: 2025년 5월 4일 오후 10:44

약세중립강세

63.1% 신뢰도

리스크 & 트레이딩

리스크 수준4/5
고위험
적합 대상
가치공격적
트레이딩 가이드

진입점

$2.07

익절

$2.19

손절

$1.84

핵심 요소

DMI는 약세 추세(ADX:11.5, +DI:7.6, -DI:15.1)를 보여 주의를 요합니다.
현재 가격이 지지선($2.07)에 매우 근접하여 강력한 매수 기회를 시사합니다.
거래량은 평균(3,452)의 6.2배로 극도로 강력한 매수 압력을 나타냅니다.
MACD -0.0027이(가) 신호선 0.0001 아래에 있어 약세 교차를 나타냅니다.

최신 정보 받기

가격 알림 설정, AI 분석 업데이트 및 실시간 시장 뉴스 받기